Clinical Research Directory
Browse clinical research sites, groups, and studies.
Investigating Phenotypic, Epigenetic, and NeuroGenetic Traits in Rare and Ultra-rare Neurodevelopmental Disorders (Project PENGUIN)
Sponsor: University of Missouri-Columbia
Summary
Rare genetic neurodevelopmental disorders, such as Syt-1 or Baker Gordon Syndrome (BAGOS) arise from mutations in genes essential for brain development and function, often disrupting neurotransmission and neuronal connectivity. These conditions present with a wide range of symptoms including developmental delays, seizures, motor and behavioral challenges, and vary widely in severity. These disorders are complex, and they remain poorly understood and lack effective treatments. Natural history and clinical genetic studies are crucial for mapping how these disorders progress, improving diagnostic accuracy, and guiding therapy development. A major focus is identifying reliable biomarkers (genetic, imaging, and physiological) to track disease severity and support clinical trials. This study will securely collect and analyze data to better understand disease impact, develop patient-derived model systems, and build resources to support future treatments.
Official title: Investigating Phenotypic, Epigenetic, and NeuroGenetic Traits in Rare and Ultra-rare Neurodevelopmental Disorders
Key Details
Gender
All
Age Range
Any - 99 Years
Study Type
OBSERVATIONAL
Enrollment
100
Start Date
2025-12-04
Completion Date
2028-12
Last Updated
2026-01-09
Healthy Volunteers
Yes
Conditions
Interventions
No Intervention: Observational Cohort
There is no intervention for this Natural History Study
Locations (1)
University of Missouri - Columbia
Columbia, Missouri, United States